Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Chemotherapy-Induced Peripheral Neuropathy × Cannabidiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Other 1

Conditions

Breast Neoplasms 2 Anxiety Disorders 2 Sturge-Weber Syndrome 1 Solid Tumor 1 Parasomnias 1 Pain 1 Nausea 1 Marijuana Abuse 1 Glioblastoma 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Cancer Pain 1 Breast Carcinoma In Situ 1 Arthralgia 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05388058 2026-01-16

Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

Mayo Clinic

Phase 2 Completed

40 enrolled 15 charts

OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡